Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease

References

• Ait-Oufella H, Pouresmail V, Simon T, et al. 2008. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol, 28(8),1429–1431. doi: 10.1161/atvbaha.108.169078.
   PubMed Web of Science ®Google Scholar
• Ammirati E, Moroni F, Magnoni M, and Camici PG. 2015. The role of T and B cells in human atherosclerosis and atherothrombosis. Clin Exp Immunol, 179(2),173–187. doi: 10.1111/cei.12477.
   PubMed Web of Science ®Google Scholar
• Arbab-Zadeh A, Nakano M, Virmani R, and Fuster V. 2012. Acute coronary events. Circulation, 125(9),1147–1156. doi: 10.1161/circulationaha.111.047431.
   PubMed Web of Science ®Google Scholar
• Aukrust P, Yndestad A, Sandberg WJ, et al. 2007. T cells in coronary artery disease: different effects of different T-cell subsets. J Am Coll Cardiol, 50(15),1459–1461. doi: 10.1016/j.jacc.2007.06.041.
   PubMed Web of Science ®Google Scholar
• Backteman K, Andersson C, Dahlin L-G, et al. 2012. Lymphocyte subpopulations in lymph nodes and peripheral blood: a comparison between patients with stable angina and acute coronary syndrome. PloS One, 7(3), e32691. doi: 10.1371/journal.pone.0032691.
   PubMed Web of Science ®Google Scholar
• Backteman K, Ernerudh J, and Jonasson L. 2014. Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation. Clin Exp Immunol, 175(1),104–112. doi: 10.1111/cei.12210.
   PubMed Web of Science ®Google Scholar
• Braun NA, Covarrubias R, and Major AS. 2010. Natural killer T cells and atherosclerosis: form and function meet pathogenesis. J Innate Immun, 2(4),316–324. doi: 10.1159/000296915.
   PubMed Web of Science ®Google Scholar
• Bruunsgaard H, Pedersen AN, Schroll M, et al. 2001. Decreased natural killer cell activity is associated with atherosclerosis in elderly humans. Exp Geront, 37(1),127–136.
   Google Scholar
• Clement M, Guedj K, Andreata F, et al. 2015. Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation, 131(6),560–570. doi: 10.1161/circulationaha.114.010988.
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Araguás ET, Baboonian C, and Kaski JC. 2009. CD4+CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res, 81(1),11–19. doi: 10.1093/cvr/cvn248.
   PubMed Web of Science ®Google Scholar
• Fauriat C, Long EO, Ljunggren H-G, and Bryceson YT. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood, 115(11),2167–2176. doi: 10.1182/blood-2009-08-238469.
   PubMed Web of Science ®Google Scholar
• Galkina E, and Ley K. 2009. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol, 27, 165–197. doi: 10.1146/annurev.immunol.021908.132620.
   PubMed Web of Science ®Google Scholar
• Gupta R, Kapuria V, and Das SN. 2009. Single nucleotide polymorphisms in TNF-α, TNFR2 gene and TNF-α production in Asian Indians. Immunol Invest, 38(3–4), 240–254. doi: 10.1080/08820130902766563.
   PubMed Web of Science ®Google Scholar
• Hak Ł, Myśliwska J, Wieckiewicz J, et al. 2007. NK cell compartment in patients with coronary heart disease. Immun Ageing, 4, 3. doi: 10.1186/1742-4933-4-3.
   Google Scholar
• Heuvel DMJvd, Chantakru S, Xie X, et al. 2005. Trafficking of circulating Pro-NK cells to the decidualizing uterus: regulatory mechanisms in the mouse and human. Immunol Invest, 34(3),273–293. doi: 10.1081/imm-200064488.
   PubMed Web of Science ®Google Scholar
• Irwin MW, Mak S, Mann DL, et al. 1999. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation, 99(11),1492–1498.
   Google Scholar
• Jabir NR, Firoz CK, Kamal MA, et al. 2016. Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients. J Clin Lab Anal, ( Accepted) doi: 10.1002/jcla.22092.
   Google Scholar
• Jabir NR, Firoz CK, Kamal MA, et al. 2017. Assessment of IL-18 serum level and their promoter polymorphisms in the Saudi coronary artery disease (CAD) patients: a case control study. J Cell Biochem, ( Accepted) doi:10.1002/jcb.25870.
   Google Scholar
• Jonasson L, Backteman K, and Ernerudh J. 2005. Loss of natural killer cell activity in patients with coronary artery disease. Atherosclerosis, 183(2),316–321. doi: 10.1016/j.atherosclerosis.2005.03.011.
   PubMed Web of Science ®Google Scholar
• Jung N-C, Lee J-H, Choi H-J, et al. 2016. Dendritic cell immunotherapy combined with cytokine-induced killer cells effectively suppresses established hepatocellular carcinomas in mice. Immunol Invest, 45(6),553–565. doi: 10.1080/08820139.2016.1183025.
   PubMed Web of Science ®Google Scholar
• Kim MH, Guo L, Kim H-S, and Kim S-W. 2014. Characteristics of circulating CD31+ cells from patients with coronary artery disease. J Cell Mol Med, 18(11),2321–2330. doi: 10.1111/jcmm.12370.
   PubMed Web of Science ®Google Scholar
• Kim W-J, Kang Y-J, Suk K, et al. 2008. Comparative analysis of the expression patterns of various TNFSF/TNFRSF in atherosclerotic plaques. Immunol Invest, 37(4),359–373. doi: 10.1080/08820130802123139.
   PubMed Web of Science ®Google Scholar
• Knorr M, Münzel T, and Wenzel P. 2014. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol, 5, 295. doi: 10.3389/fphys.2014.00295.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, and Maseri A. 2002. Inflammation and atherosclerosis. Circulation, 105(9),1135–1143.
   Google Scholar
• Liuzzo G, Kopecky SL, Frye RL, et al. 1999. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation, 100(21),2135–2139.
   Google Scholar
• Mandal A, and Viswanathan C. 2015. Natural killer cells: In health and disease. Hematol Oncol Stem Cell Ther, 8(2),47–55. doi: 10.1016/j.hemonc.2014.11.006.
   PubMedGoogle Scholar
• Marx N, Neumann FJ, Ott I, et al. 1997. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol, 30(1),165–170.
   Google Scholar
• Miyamoto K, Miyake S, and Yamamura T. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nat, 413(6855),531–534. doi: 10.1038/35097097.
   Web of Science ®Google Scholar
• Moretta L, and Moretta A. 2004. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J, 23(2),255–259. doi: 10.1038/sj.emboj.7600019.
   PubMed Web of Science ®Google Scholar
• Morris-Rosenfeld S, Lipinski MJ, and McNamara CA. 2014. Understanding the role of B cells in atherosclerosis: potential clinical implications. Expert Rev Clin Immunol, 10(1),77–89. doi: 10.1586/1744666x.2014.857602.
   PubMed Web of Science ®Google Scholar
• Mulvihill NT, and Foley JB. 2002. Inflammation in acute coronary syndromes. Heart, 87(3),201–204.
   Google Scholar
• Neri Serneri GG, Prisco D, Martini F, et al. 1997. Acute T-cell activation is detectable in unstable angina. Circulation, 95(7),1806–1812.
   Google Scholar
• Ohta H, Wada H, Niwa T, et al. 2005. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis, 180(1),11–17. doi: 10.1016/j.atherosclerosis.2004.11.016.
   PubMed Web of Science ®Google Scholar
• Packard RRS, Lichtman AH, and Libby P. 2009. Innate and Adaptive Immunity in Atherosclerosis. Semin Immunopathol, 31(1), 5. doi: 10.1007/s00281-009-0153-8.
   PubMed Web of Science ®Google Scholar
• Riccieri V, Spadaro A, Parisi G, et al. 2000. Down-regulation of natural killer cells and of gamma/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity? Lupus, 9(5),333–337.
   Google Scholar
• Ridker PM, Rifai N, Pfeffer M, et al. 2000. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation, 101(18),2149–2153.
   Google Scholar
• Rombouts M, Ammi R, Van Brussel I, et al. 2016. Linking CD11b+ dendritic cells and natural killer T cells to plaque inflammation in atherosclerosis. Mediators Inflamm, 2016, e6467375. doi: 10.1155/2016/6467375.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, and Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature, 418(6894),191–195. doi: 10.1038/nature00858.
   PubMed Web of Science ®Google Scholar
• Selathurai A, Deswaerte V, Kanellakis P, et al. 2014. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms. Cardiovasc Res, 102(1),128–137. doi: 10.1093/cvr/cvu016.
   PubMed Web of Science ®Google Scholar
• Shereck E, Satwani P, Morris E, and Cairo MS. 2007. Human natural killer cells in health and disease. Pediatr Blood Cancer, 49(5),615–623. doi: 10.1002/pbc.21158.
   PubMed Web of Science ®Google Scholar
• Sprague AH, and Khalil RA. 2009. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol, 78(6),539–552. doi: 10.1016/j.bcp.2009.04.029.
   PubMed Web of Science ®Google Scholar
• Thorp E, Cui D, Schrijvers DM, et al. 2008. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol, 28(8),1421–1428. doi: 10.1161/atvbaha.108.167197.
   PubMed Web of Science ®Google Scholar
• Tsiantoulas D, Diehl CJ, Witztum JL, and Binder CJ. 2014. B cells and humoral immunity in atherosclerosis. Circ Res, 114(11),1743–1756. doi: 10.1161/circresaha.113.301145.
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Simonetta I, and Pinto A. 2015. Cell immunity in coronary artery disease (CAD). Curr Immunol Rev, 11(1),12–23.
   Google Scholar
• van Puijvelde GHM, van Wanrooij EJA, Hauer AD, et al. 2009. Effect of natural killer T cell activation on the initiation of atherosclerosis. Thromb Haemost, 102(2),223–230. doi: 10.1160/th09-01-0020.
   PubMed Web of Science ®Google Scholar
• Wong PTY, Wong CK, Tam LS, et al. 2009. Decreased expression of T lymphocyte co-stimulatory molecule CD26 on invariant natural killer T cells in systemic lupus erythematosus. Immunol Invest, 38(5),350–364. doi: 10.1080/08820130902770003.
   PubMed Web of Science ®Google Scholar
• Yan W, Song H, Jiang J, et al. 2016. Characteristics of B cell‑associated gene expression in patients with coronary artery disease. Mol Med Rep, 13(5),4113–4121. doi: 10.3892/mmr.2016.5029.
   PubMed Web of Science ®Google Scholar
• Yan W, Zhou L, Wen S, et al. 2015. Differential loss of natural killer cell activity in patients with acute myocardial infarction and stable angina pectoris. Int J Clin Exp Pathol, 8(11),14667–1475.
   Google Scholar
• Yokoyama WM, Kim S, and French AR. 2004. The dynamic life of natural killer cells. Annu Rev Immunol 22, 405–429. doi: 10.1146/annurev.immunol.22.012703.104711.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Gardner SE, and Clarke MCH. 2011. Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol, 31(12),2781–2786. doi: 10.1161/atvbaha.111.224907.
   PubMed Web of Science ®Google Scholar
• Zuo J, Shan Z, Zhou L, et al. 2015. Increased CD160 expression on circulating natural killer cells in atherogenesis. J Transl Med, 13. doi: 10.1186/s12967-015-0564-3.
   Google Scholar